How Does Aluminum Get in Brain Tissue?

Aluminum reaches brain tissue through a multi-step journey: it enters the body through the gut, lungs, or skin, hitches a ride on blood proteins that normally carry iron, and then crosses the blood-brain barrier using the same transport systems the brain built for essential nutrients. The process is not a single event but a chain of biological loopholes, each one exploiting machinery the body designed for something else. What makes aluminum particularly tricky is that the brain clears it slowly once it arrives, so even small amounts trickling in over time can gradually accumulate.

How Aluminum Gets Into the Bloodstream

Before aluminum can reach the brain, it first has to enter the blood. The most common route is swallowing it. Aluminum is everywhere in the diet: in drinking water, processed foods, antacids, and food additives. Under normal conditions, less than half a percent of ingested aluminum actually makes it through the gut wall into the bloodstream, which sounds reassuringly low. But certain substances dramatically boost that number.

Citrate, which is abundant in citrus fruits and fruit-flavored drinks, is the best-studied absorption enhancer. Research on everted gut preparations showed that when aluminum is paired with citrate, it does not enter the body by passing through gut cells the way most nutrients do. Instead, citrate chelates free calcium, which disrupts the tight junctions between intestinal cells, essentially prying open gaps in the gut lining. Aluminum then slips through these gaps via what researchers call the paracellular pathway, mostly in the upper small intestine.

1PubMed. Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate

A small human study confirmed the pattern: after healthy men drank a fruit-based drink containing aluminum and citrate, blood aluminum peaked within about 90 minutes, and roughly 0.4% of the dose appeared in urine within 24 hours.

2PubMed. Gastrointestinal absorption of aluminium and citrate in man

Glutamate, another common food additive, has a similar effect. Animal studies found that co-administering aluminum with glutamate significantly increased aluminum retention in the brain, red blood cells, and kidneys compared to aluminum chloride alone.

3PubMed. The effects of glutamate and citrate on absorption and distribution of aluminum in rats

People who receive aluminum intravenously bypass the gut barrier entirely. This is relevant in medical settings where patients receive parenteral nutrition or certain injectable medications that contain aluminum as a contaminant. In those cases, the gut’s natural filtering role is completely circumvented.

4ScienceDirect (Elsevier) / Journal of Inorganic Biochemistry. Accumulation, elimination, and effects of parenteral exposure to aluminum in newborn and adult rats

What Happens to Aluminum in the Blood

Once aluminum enters the bloodstream, it does not float around freely. It binds to proteins and small molecules, and this binding pattern determines where it goes next. Competitive binding assays using concentrations typical of dialysis patients showed that roughly 60% of blood aluminum binds to transferrin (the protein that normally carries iron), about 34% binds to albumin, and the remainder attaches to small molecules like citrate.

5PubMed Central. Aluminium transport in blood serum. Binding of aluminium by human transferrin in the presence of human albumin and citrate.

The transferrin binding is the critical piece. Transferrin is how the body delivers iron to cells, including brain cells, and aluminum is close enough in size and charge to iron that transferrin accepts it as cargo. Among the low-molecular-weight carriers, citrate appears to be the main one, outcompeting phosphate for aluminum binding at normal serum concentrations.

6PubMed. Competition between transferrin and the serum ligands citrate and phosphate for the binding of aluminum

Computer simulations of aluminum-citrate chemistry at body pH predict that the aluminum-citrate species in blood are electrically charged, meaning they cannot passively drift through cell membranes. This matters because it rules out simple diffusion as a major route into the brain. Instead, aluminum needs active transport machinery to cross biological barriers.

7Carolina Digital Repository. Aluminum Speciation and Bioavailability: Investigations of Equilibria between Aluminum and Citrate Species in Plasma Using Computer Simulation and 27AL-NMR

Crossing the Blood-Brain Barrier

The blood-brain barrier is the brain’s gatekeeper, a tightly sealed layer of specialized cells lining the brain’s blood vessels that blocks most substances from entering. Aluminum defeats this barrier through at least two distinct mechanisms, and researchers have debated for decades which one matters more.

The first and most studied route is transferrin-receptor-mediated endocytosis. Brain cells display transferrin receptors on their surface to pull in iron. When aluminum is bound to transferrin, it rides the same receptor system into brain tissue. This was demonstrated using radiolabeled aluminum, which showed that aluminum-loaded transferrin entered the brain through the same high-affinity receptor pathway used for iron delivery.

8PubMed Central. Aluminum access to the brain: a role for transferrin and its receptor

But there is a second, faster route. When researchers injected aluminum citrate intravenously and monitored brain fluid in real time using microdialysis, aluminum appeared in the brain’s extracellular fluid too quickly to be explained by the relatively slow transferrin-receptor pathway.

9PubMed Central. Brain uptake, retention, and efflux of aluminum and manganese

Follow-up work with immortalized brain endothelial cells identified this faster route as carrier-mediated transport. Substrates and inhibitors of monocarboxylate transporters and organic anion transporters significantly reduced aluminum citrate uptake, pointing to these transporter families as the likely vehicles.

10PubMed. Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood-brain barrier transport

Microdialysis studies comparing aluminum levels in the frontal cortex versus the brain’s ventricles suggest that the primary crossing point is at the brain’s capillaries rather than at the choroid plexus, which is the structure that produces cerebrospinal fluid.

11PubMed. Dissimilar aluminum and gallium permeation of the blood-brain barrier demonstrated by in vivo microdialysis

The Nose-to-Brain Shortcut

There is one route into the brain that skips the bloodstream altogether. Inhaled aluminum particles, especially nanoparticles, can travel directly from the nasal lining into the brain along the olfactory nerve. This pathway connects the upper nasal cavity to the olfactory bulb at the brain’s base, and it has no blood-brain barrier to cross.

Animal studies using aluminum oxide nanoparticles confirmed this route. After nasal exposure, nanoparticles accumulated in the olfactory bulb, hippocampus, cerebral cortex, and striatum, causing structural damage, oxidative stress, and inflammation in those regions.

12PubMed. Neurotoxicity of aluminum oxide nanoparticles and their mechanistic role in dopaminergic neuron injury involving p53-related pathways

This route is particularly relevant for people with occupational exposure to aluminum dust or fumes, such as welders and smelter workers. It may also matter for anyone regularly inhaling fine particulate matter containing aluminum, though the dose from ambient air in most settings is far smaller than occupational exposure.

Why Aluminum Accumulates Rather Than Washing Out

The brain is not defenseless. It does have efflux mechanisms that pump aluminum back out. Microdialysis studies at steady state found that brain aluminum efflux actually exceeds influx under controlled conditions, and the main species being exported appears to be aluminum citrate, carried out by the monocarboxylate transporter.

13PubMed. The distribution of aluminum into and out of the brain

So if the brain can pump aluminum out, why does it still accumulate? The answer lies in the mismatch between steady-state lab conditions and real life. In the body, aluminum exposure is chronic and comes from multiple sources simultaneously. The efflux system can be overwhelmed by sustained intake, especially if kidney function is impaired, since the kidneys are the primary route for clearing aluminum from the body entirely. People with chronic kidney disease are at particular risk because their blood aluminum levels stay elevated for longer, giving the brain’s transport systems more time to shuttle aluminum inward. Age-related declines in kidney function may also contribute to the gradual accumulation of aluminum in aging brains.

Where Aluminum Ends Up Inside Brain Cells

Not all brain cells accumulate aluminum equally. Cell culture studies show that glial cells, the support cells of the brain, take up more aluminum and iron than neurons do. Glial cells showed higher transferrin uptake activity when exposed to aluminum, and they suppressed their transferrin receptor production more aggressively in response, both signs of greater metal accumulation. Interestingly, glial cells also appear more resistant to the oxidative damage that follows.

14Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease. Glial cells contribute more to iron and aluminum accumulation but are more resistant to oxidative stress than neuronal cells

The distribution within cells differs by cell type as well. In neurons, aluminum tends to accumulate in the nucleus, while in astrocytes (a type of glial cell) it concentrates in vesicles around the nucleus, partly overlapping with structures involved in waste digestion.

15PubMed. Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes

The nuclear accumulation in neurons is the more worrying pattern. Analysis of brain tissue from people with Alzheimer’s disease found elevated aluminum specifically in a chromatin fraction associated with DNA packaging, suggesting that aluminum physically interacts with the proteins that organize genetic material.

16PubMed. Nuclear compartmentalization of aluminum in Alzheimer’s disease (AD)

More recent imaging confirmed that aluminum and iron are colocalized in nerve cell nuclei in Alzheimer’s brains, with the highest concentrations in the nucleolus, the structure where ribosomal components are assembled.

17PubMed Central. Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer’s Disease

What Aluminum Does Once It Is Inside

Aluminum does not simply sit inert in brain tissue. It triggers several damaging processes, and many of them involve hijacking the brain’s iron chemistry. One of the most consistent findings is that aluminum potentiates iron-induced oxidative stress. In cultured hippocampal neurons, increasing the amount of aluminum inside the cell amplified the oxidative damage caused by iron and increased cell death.

18PubMed. Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons

Aluminum also disrupts the proteins that regulate iron levels inside cells. Rat studies showed that aluminum chloride exposure increased the expression of iron import proteins while decreasing the expression of iron export proteins in the hippocampus, effectively trapping excess iron inside cells. Stored iron was displaced from ferritin, raising levels of free iron that can generate damaging reactive oxygen molecules.

19PubMed. Iron Dyshomeostasis Participated in Rat Hippocampus Toxicity Caused by Aluminum Chloride

Beyond oxidative stress, aluminum appears to interfere directly with DNA packaging. Evidence supports the idea that aluminum compacts chromatin, particularly in regions rich in certain DNA bases, potentially silencing the expression of specific genes. The concern is that this could gradually impair the brain cell’s ability to produce the proteins it needs to function.

20Journal of Inorganic Biochemistry. Evidence supporting a biological role for aluminum in chromatin compaction and epigenetics

Aluminum has also been implicated in promoting the clumping of proteins linked to neurodegenerative disease. It may act as a cross-linker in the formation of beta-amyloid oligomers, the toxic clusters associated with Alzheimer’s disease.

21PubMed Central. Link between Aluminum and the Pathogenesis of Alzheimer’s Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses

Single-molecule studies showed that aluminum ions at physiologically relevant concentrations work together with tau phosphorylation to promote the formation of resistant tau oligomers and mixed oligomers containing both tau and alpha-synuclein, two proteins central to Alzheimer’s and Parkinson’s disease pathology.

22PubMed Central. Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level

Antiperspirants and Skin Absorption

One of the most common questions about aluminum and the brain involves antiperspirants, which contain aluminum compounds as their active ingredient. The concern is reasonable on its face since people apply these products daily to thin, often freshly shaved skin. But the actual absorption numbers are very small. A study using a sensitive isotope tracer found that only about 0.012% of the aluminum applied to underarm skin was absorbed, amounting to roughly 4 micrograms from a single application to both underarms.

23PubMed. A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26

A more recent study using the same tracer technique estimated an even lower absorption fraction, with a mean of roughly 0.0094% of the applied dose reaching the body.

24PubMed Central. Assessment of Dermal Absorption of Aluminum from a Representative Antiperspirant Formulation Using a 26Al Microtracer Approach

A controlled intervention study that measured blood and urine aluminum in volunteers who used antiperspirant daily for two weeks found no measurable increase in systemic aluminum load, though the authors noted that data on very long-term use is still lacking.

25Skin Pharmacology and Physiology. Impact of Daily Antiperspirant Use on the Systemic Aluminum Exposure: An Experimental Intervention Study

These findings suggest that antiperspirants contribute a very small fraction of total aluminum exposure compared to the diet. That said, the skin barrier is not uniform. Damaged skin, freshly shaved skin, and skin conditions that compromise the outer layer could allow higher absorption than these studies measured. This remains an area where more real-world data would be useful.

How Scientists Detect Aluminum in Brain Tissue

Proving that aluminum is actually in brain tissue, rather than being an artifact of tissue handling, required specialized techniques. One approach uses graphite furnace atomic absorption spectrometry to measure total aluminum, paired with fluorescence microscopy using a dye called lumogallion that binds aluminum and emits a characteristic orange glow. This fluorescence is not produced by other metals and is distinct from the brain’s natural background fluorescence, making it a reliable marker.

26PubMed Central. The Identification of Aluminum in Human Brain Tissue Using Lumogallion and Fluorescence Microscopy

A complementary technique uses morin, another fluorescent dye, with an improved protocol that better preserves tissue structure and increases sensitivity. This method has confirmed intracellular aluminum in immune cells (monocytes) and has shown aluminum co-localized with senile plaques in brain tissue from people with familial Alzheimer’s disease.

27PubMed Central. Unequivocal imaging of aluminium in human cells and tissues by an improved method using morin

These imaging advances matter because earlier criticisms of the aluminum-Alzheimer’s link focused on contamination during tissue processing. Modern methods have largely addressed those concerns, though debate about what the observed aluminum levels mean for disease causation continues.

Attempts to Remove Aluminum from the Brain

If aluminum gets into brain tissue and causes problems, the obvious question is whether you can pull it back out. The chelator desferrioxamine, originally developed for iron overload, can bind aluminum and has been tested in this context. In aluminum-loaded rats, intravenous desferrioxamine mobilized aluminum from the liver and blood, but the picture in the brain was more complicated. The aluminum-desferrioxamine complex can cross the blood-brain barrier, and in non-loaded rats, injecting this complex actually increased brain aluminum levels by allowing it to diffuse down a concentration gradient into the brain. Even in aluminum-loaded animals, brain extracellular aluminum did not decline after treatment, presumably because the complex could not diffuse back into the blood against the concentration gradient.

28PubMed. Aluminum mobilization by desferrioxamine assessed by microdialysis of the blood, liver and brain

This paradox has driven interest in alternative strategies. One approach called molecular shuttle chelation uses small chelating molecules that can penetrate the cell nucleus, grab aluminum, and then hand it off to larger chelators that can carry it out of the cell. Laboratory work showed that combining ascorbate, desferrioxamine, and a chelator called Feralex-G was effective at removing aluminum from nuclear compartments in cell culture.

29PubMed Central. Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum

Animal studies have also shown that both desferrioxamine and deferiprone can reduce brain aluminum concentrations and improve markers of protein damage associated with Alzheimer’s pathology.

30Biomedicine & Preventive Nutrition. Protective effects of deferiprone and desferrioxamine in brain tissue of aluminum intoxicated mice: An FTIR study

These chelation strategies remain experimental for brain aluminum removal in humans. The core difficulty is that once aluminum is tightly bound inside nerve cell nuclei, extracting it without damaging the cells is a fundamentally different challenge from clearing it from the blood or liver. Preventing excessive accumulation in the first place, by managing dietary exposure and maintaining kidney health, remains far simpler than reversing it after the fact.